Microbiota under pressure: how the exposome promotes chronic disease

Our environment profoundly influences our health… by acting on our microbiota. Endocrine disruptors, microplastics, medications, and ultra-processed foods are all components of the exposome that weaken our gut ecosystem and promote chronic diseases.

The gut microbiota The skin microbiota The pulmonary microbiota Psychiatric disorders Asthma and microbiota Stomach Cancer Irritable bowel syndrome (IBS)
Exposure to air pollution disturbs the microbiota of babies

Psychiatric disorders

A number of studies have shown that exposure of the gut microbiota to environmental factors has consequences for mental health:

Moreover, an imbalance in the microbiota can expose the brain to disturbances via the gut-brain axis. A gut dysbiosis may thus be involved in the initial onset of psychosis. 

What role does the microbiota play in the gut-brain axis?

Learn more

Asthma and allergic diseases

The number of people affected by allergic diseases continues to rise worldwide. This surge in allergies may well originate in the exposome.

A growing number of studies suggest that exposure to environmental substances (air pollution, detergents, microplastics, nanoparticles, processed foods, emulsifiers, etc.), as well as the decline in biodiversity and environmental degradation, are responsible for changes that favor these immune disorders:

1 in 4 Europeans suffer from allergies.

50 % of people in industrialized countries will be affected by allergies by 2050.

10 to 30 % of the world’s population suffers from at least one allergic disease 27.

At gut level, certain exposure factors have been shown to damage epithelial barriers, resulting in dysbiosis and increased permeability. This is thought to be responsible for a loss of the “immunomodulatory” (allergy-protective) effects of bacteria in the  microbiota 25 . 

Does an unbalanced microbiota at age one lead to allergies at age five?

Learn more

Cancer and bowel diseases

More and more young people are being diagnosed with cancer, including bowel cancer. Over the past three decades, the incidence of cancer has risen by around 50% among people aged 25 to 49 in the US, Canada, Australia, and several European countries. 

2.4 times higher The increase in the risk of colon cancer among those born in 1990 compared to those born in 1950.24

30 % The share of ultra-processed foods in the daily calorie intake in France (up to 60% in the UK and the US). ,

Multiple environmental factors

A lack of fiber, the consumption of red meat and processed foods, and exposure to pollutants have all been singled out, but suspicion also falls on a host of other environmental factors, such as food, beverages, medication, air pollutants, and chemicals, whose individual effects on our cells and microbiota are beginning to be understood 28. 

The same is true of chronic inflammatory bowel disease (IBD), the highest incidence of which is found in the most industrialized countries, such as those in north-western Europe and the United States, and whose frequency increases with socio-economic development. 

Although the causes of IBD remain poorly understood, dysbiosis is known to play an important role 29.  

According to a team of French researchers, there’s growing evidence that ultra-processed foods (UPFs), in particular food additives, play a role in IBD, colorectal cancer, and irritable bowel syndrome. In particular, emulsifiers, sweeteners, colorants, microplastics, and nanoparticles are known to affect the gut microbiota, intestinal permeability, and intestinal inflammation, with a potentially significant impact on the risk of intestinal disease 30. 

Read the rest of the article

From birth to death, an exposome with different consequences on our health

Continue reading

Back to previous page

Exposome explained by our expert

Explore the playlist
Sources

1. Kimmel MC, Verosky B, Chen HJ, et al. The Maternal Microbiome as a Map to Understanding the Impact of Prenatal Stress on Offspring Psychiatric Health. Biol Psychiatry. 2024 Feb 15;95(4):300-309.

2. Madison AA, Bailey MT. Stressed to the Core: Inflammation and Intestinal Permeability Link Stress-Related Gut Microbiota Shifts to Mental Health Outcomes. Biol Psychiatry. 2024 Feb 15;95(4):339-347. 

3. Ross FC, Mayer DE, Gupta A, et al. Existing and Future Strategies to Manipulate the Gut Microbiota With Diet as a Potential Adjuvant Treatment for Psychiatric Disorders. Biol Psychiatry. 2024 Feb 15;95(4):348-360.

4. Fond G. Bien manger pour ne plus déprimer, Odile Jacob, 2022.

5. Institut Pasteur, Tackling allergies, avril 2018

6. Shin YH, Hwang J, Kwon R, et al. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy. 2023 Aug;78(8):2232-2254.

7. Losol P, Sokolowska M, Hwang YK, et al. Epithelial Barrier Theory: The Role of Exposome, Microbiome, and Barrier Function in Allergic Diseases. Allergy Asthma Immunol Res. 2023 Nov;15(6):705-724.

8. PROSPECT Study

9. Salomé M, Arrazat L, Wang J, et al. Contrary to ultra-processed foods, the consumption of unprocessed or minimally processed foods is associated with favorable patterns of protein intake, diet quality and lower cardiometabolic risk in French adults (INCA3). Eur J Nutr. 2021

10. Inrae, juin 2022.

11. Inserm

12. Whelan K, Bancil AS, Lindsay JO, Chassaing B. Ultra-processed foods and food additives in gut health and disease. Nat Rev Gastroenterol Hepatol. 2024 Jun;21(6):406-427.

Summary
On
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

Microbiota and exposome: a dialog at the core of our health

Everything we eat, breathe, or apply to our bodies comes into contact with our microbiota, resulting in a non-negligible impact on our health. 

The gut microbiota The vaginal microbiota The pulmonary microbiota The skin microbiota The ENT microbiota Diet: a key factor

The problem is that many features of the external exposome (low-fiber or high-fat diet, emulsifiers, heavy metals, phthalates, microplastics, fine air particles, pesticides, environmental pollutants, stress, etc.) can upset the balance of our microbiota and lead to dysbiosis. 

We know that dysbiosis is linked to numerous chronic diseases, such as obesity, type 2 diabetes, asthma, chronic inflammatory bowel disease, autoimmune diseases, depression, and cerebral development disorders 1. 

Collapse of biodiversity = microbiota and health at risk

This ticking time bomb has been confirmed by international expert group IPBES : biodiversity is “declining globally at rates unprecedented in human history” 13 . This collapse is the result of global warming, over-exploitation of land, and pollution. 

That’s a problem for our microbiota, since fewer animal and plant species means less microbial diversity in ecosystems and therefore more alteration of microbiota-mediated immunomodulatory circuits, as well as more allergies and autoimmune diseases 14. 

Microbiota: a well-connected network that influences health

Learn more

According to the World Allergy Organization, the loss of biodiversity results in reduced interaction between environmental and human microbiota, which can lead to immune dysfunction and impaired tolerance mechanisms 15. 

On the other hand, we’ve known since 2005 that microbe-rich environments (living on a farm, close to nature, etc.) are associated with protection against immune diseases. 

Beneficial effects of the exposome

“Environmental factors” are often associated with “adverse health effects”. But let’s not forget that part of the exposome is beneficial to our organism. According to a team of American and German researchers, exposure to daylight, green spaces, biodiversity, physical activity, social and emotional support, and a Mediterranean diet have all been shown to improve stress resilience, immune balance, and our circadian rhythm (body clock) 16. 

Fungal exposome: regulating the immune response

The microbiota, whether in the gut, vagina, lungs, or on our skin, comprises not only bacteria, but also viruses, archaea... and fungi. The fungal “mycobiota” is essential to the balance and stability of our microbiota. Numerous studies on infants have shown the microbiota fungal composition to be associated with the risk of developing an allergic disease. 

Peanut allergy explosion: climate to blame?

In the US, peanut allergy in children increased by 21% between 2010 and 2017. 

Is climate change to blame? This may well be the case, according to several studies showing that increases in CO2 and temperature are correlated with physiological changes in peanut plants. These may produce seeds with an altered antigenic profile that promote allergies 18.  

We now know that the mycobiota largely depends on the fungal exposome. Analyses of fungal taxa have shown that the fungi most frequently found in the gut, mouth, lungs, and on the skin are the same as those found in the environment, whether indoors (walls, furniture, indoor air, etc.) or outdoors (food, water, soil, etc.).  

Fungi present everywhere in the environment may therefore come into sustained contact with our organism, modulating our immune responses.

Do fungi in the nose play a role in rhinitis and asthma?

Learn more

Drugs, exposome, microbiota: a delicate balance  

As part of our exposome, drugs interact in complex ways with the gut microbiota, influencing both its composition and functions. 

Take, for example, common treatments such as proton pump inhibitors (PPIs), used to treat gastroesophageal reflux disease. PPIs modify the acidic environment of the stomach, allowing oral bacteria to reach the gut. This can influence the microbial ecosystem by favoring the growth of certain strains. These changes are associated with an increased risk of infection, such as those caused by Clostridium difficile, but can be controlled through appropriate use (avoiding long-term treatment where possible) and medical follow-up 20.  

The  microbiota is no mere bystander. It plays an active role in the processing of drugs. 

For example, gut bacteria can improve the efficacy of metformin (an anti-diabetic drug) by stimulating the production of (sidenote: Short chain fatty acids (SCFA) Short chain fatty acids (SCFA) are a source of energy (fuel) for an individual’s cells. They interact with the immune system and are involved in communication between the intestine and the brain. Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. ) (SCFAs) beneficial to health. 

Conversely, in rare cases, the  microbiota can transform active molecules into toxic compounds, as in the case of brivudine, a now-banned antiviral used to treat shingels, which gut microorganisms can convert into liver-toxic bromovinyluracil.

Image
microbiote-antibiotique-focus1_EN

These interactions highlight the importance of better understanding the relationships between drugs,  microbiota, and exposome. By taking these mechanisms into account, we can optimize treatments and develop therapeutic strategies that respect and support the fragile balance of our gut ecosystem.

Read the rest of the article

Microbiota under pressure: how the exposome promotes chronic disease

Continue reading

Back to previous page

Exposome explained by our expert

Explore the playlist
Sources

1. Lionel Cavicchioli. Un organe sensible aux pollutions, Le Figaro Santé, avril-mai-juin 2024.

2. Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES)

3. IPBES. Nature’s Dangerous Decline ‘Unprecedented’; Species Extinction Rates ‘Accelerating’. Press Release, 6 May 2019.

4. Ray C, Ming X. Climate Change and Human Health: A Review of Allergies, Autoimmunity and the Microbiome. Int J Environ Res Public Health. 2020 Jul 4;17(13):4814.

5. Haahtela T, Holgate S, Pawankar R, et al. WAO Special Committee on Climate Change and Biodiversity. The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J. 2013 Jan 31;6(1):3.

6. Hahad O, Al-Kindi S, Lelieveld J, et al. Supporting and implementing the beneficial parts of the exposome: The environment can be the problem, but it can also be the solution. Int J Hyg Environ Health. 2024 Jan;255:114290.

7. Gupta, R., Warren C., Blumenstock J. et al. OR078 The prevalence of childhood food allergy in the United States: an update. Annals of Allergy, Asthma & Immunology, Volume 119, Issue 5, S11, November 2017.

8. Beggs, P.J., Walczyk, N.E. Impacts of climate change on plant food allergens: a previously unrecognized threat to human health. Air Qual Atmos Health 1, 119–123 (2008).

9. Vitte J, Michel M, Malinovschi A, et al. Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy. Allergy. 2022 Nov;77(11):3199-3216.

10. Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut. 2020 Aug;69(8):1510-1519.

Summary
On
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

Exposome: exposed microbiota puts health at risk

Have you ever noticed that some people seem to get sick more often than others? Behind this inequality lies a concept as holistic as it is revolutionary: the exposome. All the environmental factors we’re exposed to throughout our lives influence our health more profoundly than we realize. The microbiota may well play a central role. Explanations below. 

The gut microbiota The skin microbiota The vaginal microbiota The pulmonary microbiota Diet: a key factor

The food we eat, the water we drink, the air we breathe, not to mention our living and working environment... To what extent do the factors we’re exposed to from cradle to grave play a role in the relentless advance of chronic disease? This question poses a real challenge for the scientific community. 

350 000 The number of different man-made synthetic chemicals present in the environment today 5.

9 millions The number of people who die prematurely each year from the cumulative effects of environmental exposure (12.6 million according to WHO ).

24 % The percentage of deaths worldwide caused by environmental factors (28% of deaths in children under the age of five).

While scientists have been working for many years to measure the impact on health of each of these factors, we still know very little about the physiological harm they cause when combined and accumulated over the years.

Some act synergistically (cocktail effect), while others offset each other. Furthermore, their impact differs according to the stage of life when one is exposed to them and on the duration of exposure1. 

Nature and microbiota: how does it affect your health?

Learn more

Exposome: a global approach to health

Urbanization, stress, climate change, modern diet, toxic products... In 2005, driven by the need to better understand the often complex exposure to these multiple environmental factors, British epidemiologist Christopher P. Wild (current director of the International Agency for Research on Cancer – IARC) proposed the concept of “exposome”. Wild defines the exposome as “the sum of all exposures a person experiences from conception to death.” 

He sees the exposome as“a complex and dynamic representation of the exposures we experience during our lifetime that integrates chemical, microbiological, physical, recreational, medicinal, lifestyle and dietary environments, as well as infections.”2  

Genome and exposome: complementary, my dear Watson! 

Beware of shortcuts – and easy explanations – that contrast genome and exposome. On the contrary, they complement each other. The exposome echoes the concept of the genome and comprises all non-genetic factors that influence our health. It complements the genome-centric approach, which, by limiting itself to genes and chromosomes, offers only a partial understanding of the onset of disease. 

For Christopher Wild, chronic disease can be explained by interactions between our genes and the environment, hence the need for methodological tools to develop and improve the sciences of exposure, which are still insufficiently taken into account. 

Breathing, washing, dressing, eating, working, and sleeping are not so trivial after all. They expose us to sources of micro-particles, chemicals, pollutants, heavy metals, stress, noise, radiation... all potentially harmful to our bodies and microbiota.

From exposome to the One Health initiative: acting globally

It’s no secret that our health is intimately linked to that of the animals, plants, and microorganisms living on Earth. 

We all belong to the same ecosystem, and the interactions between humans, flora, and fauna and our environment shape our collective health. We’re all exposed to the same contaminants, whether chemical pollutants, pathogens, or the effects of climate change.

The concept of the exposome thus fits naturally into a global approach like One Health. The One Health initiative is recognized by the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), and the World Organization for Animal Health (WOAH) and highlights the interdependence between human, animal, and environmental health.3

A better understanding of the exposome, i.e. the exposures we experience during our lifetime, is therefore crucial to reducing the risk of disease and making good habits part of our daily lives. But what about the microbiota? 

Microbiota and exposome: a dialog at the core of our health 

What if our health depended on the dialogue between our environment and the billions of micro-organisms that inhabit our bodies? Pollutants, food, stress, nature... the exposome constantly interacts with our microbiota and can influence their fragile balance. A little-known but central link, particularly in the prevention of chronic diseases. The impact of nature on our microbiota, and that of urbanization, bear witness to this.

Discover how this silent exchange shapes our health.

Microbiota and exposome: a dialog at the core of our health

Read more

Microbiota under pressure: how the exposome promotes chronic disease

Our environment has a profound influence on our health... by affecting our microbiota. Endocrine disruptors, microplastics, drugs, ultra-processed foods: these are all components of the exposome that weaken our intestinal ecosystem and promote chronic disease. Science is now revealing how these disturbances can lead to obesity, depression, IBD and allergies. Examples include the fungal exposome and bacterial resistance.

Explore the links between environment, dysbiosis and modern diseases

Microbiota under pressure: how the exposome promotes chronic disease

Explore this topic!

From birth to death, an exposome with different consequences on our health

Our sensitivity to the environment evolves with age. From pregnancy onwards, the exposome modulates immunity, shapes the infant's microbiota and influences his or her future risk of asthma or allergy. In adolescence, it impacts mental and skin health. In adulthood, it determines inflammation and overall well-being. In senior citizens, it can preserve or alter longevity, as shown by the study on the microbiota of centenarians.

Discover how each stage of life interacts with the exposome.

From birth to death, an exposome with different consequences on our health

Learn more

Towards a more favorable exposome 

We may not have everything under control, but we can do something about it! A beneficial exposome is possible: a fiber-rich diet, physical activity, living in contact with nature, gentle hygiene, reducing disruptors... all simple levers to protect our microbiota and prevent disease. The Mediterranean diet and a rich microbial environment are living proof of this.

23 % The percent decrease in mortality among women whose diet is the closest to the Mediterranean diet compared with those the furthest from it.

25 % The percent decrease in cancer risk among those who follow an organic diet (-34% for breast cancer).

Discover concrete ways to cultivate a healthy environment.

Towards a more favorable exposome

Explore this topic!

Microbiota are the sentinels of our environment. Living interfaces between our bodies and the outside world, microbiota are a faithful reflection of our environment. Understanding the exposome means identifying the levers we need to live better, age better and prevent the diseases of tomorrow. The exposomic approach sheds new light on our relationship with public health, ecology and everyday behavior.

Exposome explained by our expert

Explore the playlist
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Article Off

The impact of puberty on girl's microbiota

What happens to a girl’s microbiota as she grows up? From early childhood to puberty, the microbiota gut, skin, and vaginal evolves constantly. Diet, environment, hygiene habits, and hormones all play a role.

But what’s normal? How do puberty and periods change things? Why do some girls get more infections or skin issues than others? Backed by science, this section explores how these microbial shifts can affect immunity, mood, and overall health and how girls can support their microbiota every step of the way.

Microbiota development in children

Before talking about puberty, let's discuss microbiota development in children. From the gut to the skin, a child’s microbiota plays a key role in their health, shaped by early-life stages, allergies, and environmental factors. Explore how microbes impact immunity and disease risk in children's life.

What about the gut microbiota

What do we really know about how a child’s gut develops? From colic to antibiotics, and immunity to early life stages, explore the latest research answering parents’ top questions about the microbiota's role in child health.

What about allergies?

Childhood allergies, including food, respiratory, and skin allergies, are increasingly linked to microbiota development. Explore how early microbial influences shape allergy risks from pregnancy to early childhood.

Impact of environment on a child’s microbiota

How does the environment shape a child’s microbiota?

From exposure to nature to daily interactions with pets and family, explore the latest research on how environmental factors influence gut, skin, and other microbiota in childhood development.

Intimate hygiene & girl's microbiota

What does your hygiene have to do with your microbiota? A lot, actually! From your period to daily habits, the way you care for your body can shape your vaginal and gut microbiotas and protect you from infections like UTIs or thrush. Want to know what’s normal, what’s not, and how to stay balanced? Let’s clear things up.

How is microbiota formed?

How is a girl’s microbiota formed, and why does it matter for her health? From birth to adolescence, learn how her gut and intimate microbiota shape hygiene, immunity, and well-being, with tips for girls to maintain balance as they grow.

How to take care of your intimate microbiota

How does a girl’s microbiota affect her health? From vaginal hygiene to menstruation, early habits shape the balance of gut and vaginal microbiotas. Discover why understanding and protecting these ecosystems from a young age is key to preventing infections, bacterial vaginosis, or toxic shock syndrome.

Vaginal infections & microbiota

Vaginal and intimate infections in girls are linked to microbiota imbalances. But what causes these imbalances? Discover how hygiene, lifestyle, and diet affect the vaginal microbiota, and learn about these infections and how to prevent them.

Puberty, hormones & microbiota

Puberty triggers hormonal changes that have a profound effect on the microbiota across the gut, skin, and intimate regions. Delve into how these shifts influence key aspects of teen health, from mood and skin conditions like acne to overall well-being.

Fluctuating hormones & intimate microbiota

Puberty brings hormonal fluctuations that can significantly affect the intimate microbiota. Explore how these hormonal changes impact the vaginal microbiota, and dive into the latest findings on how hormones and contraceptives shape microbiota health.

First periods & intimate microbiota

The onset of periods marks a major change, but how does it affect the intimate microbiota? Discover why you may experience painful periods and how the menstrual cycle, contraceptives, and the vaginal microbiota are all connected.

Caring for the intimate microbiota

Caring for the intimate microbiota is key to health, especially during puberty. Discover how to maintain a balanced vaginal microbiota and prevent infections like bacterial vaginosis with the latest insights on hygiene and hormones.

Other impact of puberty on teenagers

Puberty brings significant hormonal changes that deeply influence the microbiota. Discover how these shifts affect the gut, skin, and intimate microbiota, playing a key role in mood, acne, and overall well-being during the teenage years.

What women know (and don't know)

about their vaginal microbiota

What is the link between microbiota and women’s health? The International Microbiota Observatory, based on a survey of 7,500 people across 11 countries, explores women’s knowledge, perceptions and behaviours of their gut, vaginal, and urinary microbiota. The 2024 edition reveals a global lack of awareness, growing interest in the role of microbiota in hormonal, digestive, and intimate health, and a strong demand for better prevention, education, and support. Dive into the full report to discover key insights, data highlights, and what women worldwide really know about their microbiota.

Discover the 2024 International Microbiota Observatory survey

Explore the results
BMI 25.11
Summary
Off
Hide image
Off
Article

Towards worldwide redefinition of healthy vaginal microbiota

Is our view of the vaginal microbiota too bacteria-centric and ethnocentric? So suggests an opinion piece 1 written by renowned researchers calling for more research into the diversity of vaginal microbiota worldwide and highlighting its key role in women’s health and in preventing certain infections.

The vaginal microbiome is crucial to gynecological health. But with one main difference: unlike many other microbiomes, where healthy means diverse, the “gold standard” for a healthy vaginal flora is (at present) an ample predominance of Lactobacilli. 

The predominance of Lactobacilli, particularly L. crispatus, is currently associated with increased protection against certain infections, including sexually transmitted infections, as well as a lower risk of complications during pregnancy. This may explain why their predominance serves as the benchmark for a healthy vaginal microbiota.

However, in an opinion article on vaginal health, a group of international experts have pointed out the limitations of the current five (sidenote: Five community state types (CST) - CST I dominated by Lactobacillus crispatus, 
- CST II dominated by L. gasseri,
- CST III dominated by L. iners 
- CST V dominated by L. jensenii
- and the more diverse CST IV, which is not dominated by Lactobacillus but by a group of anaerobic bacteria, including Gardnerella, Atopobium, Prevotella, and Finegoldia. 
 
)
classification: it does not reflect the full biology and functionality of the vaginal microbiome. The authors cite the Belgian Isala study, where 10.4% of participants displayed a co-dominance of L. crispatus (CST I) and L. iners (CST III), suggesting that CSTs may co-exist in some women. Another limitation is that the role of fungi, eukaryotes, archaea, and viruses remains largely unexplored.

Data mainly from wealthy countries

To illustrate their point, the authors considered bacterial vaginosis. This condition is diagnosed using the (sidenote: Nugent score A diagnostic scoring system used to assess bacterial vaginosis based on the presence and proportions of certain bacteria in a Gram-stained vaginal sample. ) or the (sidenote: Amsel criteria The Amsel criteria might provide a more clinical diagnosis of BV because they are based on the following four signs: vaginal fluid pH above 4.5, positive whiff test (foul odor after adding 10% potassium hydroxide – KOH), presence of clue cells, and abnormal vaginal discharge. At least three of these signs must be present before BV is diagnosed. ) , but these systems suffer from biases, particularly geographical biases.

Bacterial vaginosis is a very common cause of vaginal discharge among women of reproductive age.

The prevalence of bacterial vaginosis varies across countries and population groups, but according to a recent systematic review and meta-analysis, the global BV prevalence among women of reproductive age ranges from 23 to 29%. Bacterial vaginosis increases the risk of contracting and transmitting infections such as HIV and other STIs and, if left untreated, can have adverse effects during pregnancy. 2

In 2024, the WHO published Recommendations for the treatment of Trichomonas vaginalis, Mycoplasma genitalium, Candida albicans, bacterial vaginosis and human papillomavirus 3 (‎anogenital warts)‎ to provide evidence-based clinical and practical recommendations on case management of bacterial vaginosis.

Is the lower presence of Lactobacilli and higher frequency of vaginosis in black and Latin American women (vs. women of Asian or European origin) in the United States real or simply due to methodological limitations? Could socioeconomic inequalities between populations explain some of the differences? What about different behaviors, such as douching, a noted risk factor for vaginal dysbiosis? What about the many American women classified as African American even though (more than) half of their ancestors were white Europeans?

Ultimately, what do we really know about the make-up of a “healthy” and balanced vaginal microbiota in women with distinct geographical and ethnic origins?

Projects on every continent

The authors highlight the lack of studies in low- and middle-income countries, despite a growing number of initiatives attempting to fill this gap:

  • The Vaginal Human Microbiome Project (VaHMP) maps data on the vaginal flora of women from different ethnic backgrounds in the United States;
  • The VIRGO database supplements the US data with data from six countries on different continents;
  • The Vaginal Microbial Genome Collection (VMGC) contains data from 14 countries; 
  • The Vaginal Microbiome Research Consortium has a specific section for Africa and Bangladesh.

Another approach is citizen science (public contribution to vaginal microbiome research around the world using a bottom-up, local approach), such as the authors’ Isala project on vaginal flora. Following its success in Belgium (more than 6,000 applications for 200 women sought), the initiative has been extended to a global network of partners on different continents (the Americas, Africa, Asia, and Europe), promoting collaboration between teams.

The authors consider all these initiatives necessary for a more complete understanding of a “healthy” vaginal microbiome. 

How to talk about women's health: Pr. Graziottin's advice

Learn more

These advances may also help us to better understand the conditions that promote a balanced vaginal microbiota, in particular by further investigating the protective role of certain species, such as Lactobacillus crispatus, and by rigorously evaluating the benefits of probiotics in this equation.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Gynecology General Medicine
Social media image

When sodas harm your microbiota and your health

Can sodas and other sugary drinks alter our intestinal flora and, as a result, increase our risk of diabetes? This is what researchers 1 found when they studied the gut microbiota of Hispanic and Latino Americans.

The gut microbiota Diet: a key factor Type 2 diabetes

Sodas and other sugary drinks are a major target of public health policies. The harmful effects associated with consuming too many of them include (sidenote: Diabetes mellitus Chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Over time, diabetes can damage blood vessels in the heart, eyes, kidneys and nerves. ) , more specifically type 2 diabetes. How does this happen? Undoubtedly through weight gain, (sidenote: Insulin-resistance An altered response of cells to the action of insulin (a hormone that helps the body use sugar for energy), insulin resistance results in poor regulation of blood sugar levels. Sources
Inserm. La résistance à l’insuline, une histoire de communication. 2018. 
Centers for disease control and prevention. Diabetes - Resources and Publications -Glossary 
)
, inflammation and dyslipidemia. But research carried out on Hispanic and Latino Americans shows that our gut microbiota also plays a role.

422 million The number of people living with diabetes has been rising, from 108 million in 1980 to 422 million in 2014. The disease was directly responsible for 1.5 million deaths in 2012 alone. ²

10,043 diabetes deaths associated with sugar-sweetened beverage intake among U.S. adults in 2012, contributing to 14.8% of diabetes deaths related to suboptimal diets. ¹

More sodas, more bad bacteria

A weakness for sugary drinks (especially if you drink more than 2 glasses a day) has serious consequences for the gut microbiota. In fact, regular consumption of these drinks appears to reduce the number of various bacteria that are considered beneficial because they produce (sidenote: Short chain fatty acids (SCFA) Short chain fatty acids (SCFA) are a source of energy (fuel) for an individual’s cells. They interact with the immune system and are involved in communication between the intestine and the brain. Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. ) (SCFAs), which are known for their protective effects.

For example, Bacteroides pectinophilus, which feeds on pectin but doesn't know what to do with the sugars found in sodas, declines when soda is consumed. However, this isn’t true of all bacteria: those that like to feed on fructose and glucose (two sugars found in high amounts in sugary drinks) multiply like wildfire.

WHO recommends

WHO recommends that if people do consume free sugars, they keep their intake below 10% of their total energy needs, and reduce it to less than 5% for additional health benefits. This is equivalent to less than a single serving (250 ml) of commonly consumed sugary drinks per day. 2

Diabetes-linked bacterial metabolites 

As a direct consequence of this bacterial disturbance, our microbiota changes, so it no longer produces the same (sidenote: Metabolites Small molecules produced during cellular or bacterial metabolism. For example, short-chain fatty acids are metabolites produced by intestinal microbiota during fermentation of non-digestible complex carbohydrates (fibers, etc.). Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25.  Lamichhane S, Sen P, Dickens AM, et al An overview of metabolomics data analysis: current tools and future perspectives. Comprehensive analytical chemistry. 2018 ; 82: 387-413 ) and it impacts our health differently. With sodas, we're no longer getting the good SCFAs that are so beneficial for our bodies! Instead, the molecules produced by the intestinal flora of people who drink a lot of sugary drinks are linked to blood sugar issues and the risk of diabetes. And the more sodas and sugary drinks you consume, the greater the presence of these harmful molecules in your blood, leading to an increased risk of diabetes.

Note: being overweight could play a role in this phenomenon, as extra pounds seem to be part of the link between sugary drinks, metabolites and diabetes.

Increasing sugary drink intake (sugar-sweetened beverages or fruit juices) by 110 ml (half a glass) for 4 years increases the risk of type 2 diabetes by 16% in the following 4 years (compared with people whose consumption remains stable over time). 3

It’s time to cut down on sodas

These findings suggest that the gut microbiota and bacterial metabolites may play a role in the link between drinking sugary drinks and an increased risk of diabetes. Of course, further studies on other populations are still needed to better understand this link. But in the meantime, this study should be seen as yet another reason to drink less sodas! Instead, how about a glass of horchata, which boosts good bacteria?

The gut microbiota

Learn more
Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

The microbial-metabolic nexus in colon cancer

Cutting-edge colon adenocarcinoma research reveals how fatty acid metabolism, intratumoral microbiota, and the tumor microenvironment shape patient outcomes, paving the way for AI-driven diagnostic innovations in cancer care.

Intratumoral dynamics in colon cancer are complex, with microbiota, (sidenote: Fatty Acid Metabolism (FAM) The cellular process involved in breaking down and synthesizing fats, influencing tumor growth and progression. ) , and the (sidenote: Tumor Microenvironment (TME) The surrounding environment of a tumor, including immune cells, blood vessels, and signaling molecules that impact cancer development. ) all playing a role. A recent study 1 delved into this "unresolved trinity" in (sidenote: Colon Adenocarcinoma (COAD) A type of colon cancer originating in the glandular cells of the colon. ) . By leveraging a substantial cohort of patient data from The Cancer Genome Atlas (TCGA) and employing sophisticated bioinformatic and pathological image analysis techniques, the researchers aimed to uncover novel diagnostic and therapeutic avenues for this aggressive cancer.

Microbial-metabolic connections

The research team initiated their investigation by analysing comprehensive data from 420 patients diagnosed with COAD. A key methodological step involved categorising these patients into two distinct subgroups:

  • those exhibiting high fatty acid metabolism (FAM_high)
  • and those with low fatty acid metabolism (FAM_low).

This stratification based on the (sidenote: Gene Set Variation Analysis (GSVA) A computational method used to evaluate the activity of specific gene pathways in patient samples, aiding in diagnostic subtyping. ) score calculated for FAM pathway genes.

Surprisingly, despite the overall microbial alpha diversity (a measure of within-sample diversity) appearing similar between the two groups, deeper analysis of the microbial beta diversity (a measure of between-sample diversity) revealed remarkably distinct bacterial compositions strongly linked to these underlying metabolic profiles.

Specific types of gut-associated bacteria were found to play a role in modulating the tumor environment. Notably, the study identified a panel of specific bacterial genera, including Desulfovibrio, Desulfococcus, Streptococcus, and Mycobacterium, that were significantly enriched within the FAM_high patient group, showing a clear connection between the (sidenote: Intratumoral Microbiota The community of microorganisms present within the tumor, which can affect its behavior and the patient's prognosis. ) and host metabolism. This metabolic stratification also had prognostic significance.

The researchers observed that patients whose tumors exhibited a low FAM signature (FAM_low group) experienced significantly better overall survival (OS) compared to their FAM_high counterparts. The identification of four specific genes (ADIPOR2, HAO2, ALAD, HPGD) whose expression levels were significantly correlated with patient survival, solidifying the critical prognostic role of FAM in COAD.

Metabolic signatures as predictive tools

Beyond diagnosis and prognosis, the study's comprehensive drug sensitivity analysis illuminated substantial and potentially clinically actionable differences in how the two FAM-defined subtypes responded to a broad spectrum of therapeutic agents.

By calculating the IC50 values (the concentration of a drug required to inhibit 50% of cells) for an extensive panel of 195 candidate drugs, the researchers uncovered that the FAM_high and FAM_low groups exhibited significantly different sensitivities to a remarkable 120 of these compounds. For example, the high FAM group showed less sensitivity to drugs like JQ1, suggesting these agents might be less effective in this metabolic context. Such insights could support more personalized cancer treatment strategies.

Imaging insights for diagnosis

Perhaps most notably, the research found that standard histopathology images can reflect the underlying FAM subtypes. Distinct texture features correlated with FAM scores and microbial signatures, differing significantly between the high and low FAM groups. AI models could soon analyze histology to detect bacterial signatures and tumor metabolism status in real time. This suggests the exciting possibility of developing AI-powered tools to predict metabolic subtypes from routine pathology, offering a cost-effective and accessible diagnostic approach.

This research provides significant insights into the intricate relationship between the gut and tumor environment in COAD progression.. The potential for non-invasive metabolic subtyping through AI-driven image analysis holds particular promise for broad clinical translation. A deeper understanding of how gut-derived bacteria interact with tumor cells will be key to future therapeutic advances.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Oncology Gastroenterology General Medicine

Downside of fruit and vegetable juices for gut health

According to a new study, fruit and vegetable juices consumed as part of a detox regimen or to supplement a diet too low in plant-based foods may harm our oral and gut microbiota.

The gut microbiota The ENT microbiota Diet: a key factor

When it comes to nutrition, fruit and vegetable juices provide a vitamin, mineral, and antioxidant boost. However, according to a clinical trial published in the journal Nutrients, “detox juice cleanses” may not be the best option when it comes to the recommended “five portions of fruit and vegetables a day”. 1

Students on a diet

The authors put 14 students on three different diets for three days:

  • five followed a diet consisting exclusively of cold-pressed fruit and vegetable juices (800 to 900 kcal per day, i.e. about 10 glasses); 
  • four followed a “normal” diet accompanied by fruit and vegetable juices; while
  • five followed a low-calorie diet rich in “whole” plant foods containing fiber (800 to 900 kcal).

Before starting their respective diets, in order to assess the influence of different foods on microbial composition, all participants followed a three-day “elimination diet” consisting of organic fruit, vegetables, whole grains, and eggs, with very little or no red meat, dairy products, processed foods, gluten, alcohol, coffee, or sugar.

To analyze how the different diets impacted the microorganisms in the volunteers’ gut, oral, and salivary microbiota, the researchers collected samples from their stool, saliva, and from the inside of their cheeks before the experiment, between the two diets, and afterwards.

Are vegetarian and vegan diets healthy?

Learn more

Increased risk of periodontitis and tooth decay

They found that fruit and vegetable juices, whether consumed alone or with food, significantly alter the oral microbiota by increasing pro-inflammatory bacteria, even if these changes are temporary.

The researchers noted a reduction in Veillonellaceae, a bacterium capable of converting salivary nitrates into nitrites. However, fewer nitrites means less effective inhibition of the bacteria responsible for periodontitis and an increased risk of tooth decay.

For the gut microbiota, the impact of juices was less pronounced, but the researchers noted an increase in bacteria associated with inflammation, intestinal permeability, and cognitive decline.

The gut microbiota

Learn more

Too much sugar, too little fiber

According to the authors, juices are higher in sugar and carbohydrates, and lower in fiber than whole fruits and vegetables, which adversely impacts both the oral and gut microbial flora.

Fruit and vegetables: benefits galore ¹ ²

• By lowering blood sugar spikes and promoting satiety and weight maintenance, fruit and vegetables help fight diabetes and obesity.

• Their phenolic compounds promote insulin sensitivity and the breakdown of body fat. 

• Their polyphenols increase the diversity of gut microorganisms.

• Their fiber is an energy source for bacteria in the microbiota and a substrate for the production of fatty acids beneficial to our metabolism, immunity, and health.

The elimination diet had the most positive impact on the gut microbiota: by providing more fiber, it promoted the growth of bacteria that produce highly beneficial (sidenote: Short chain fatty acids (SCFA) Short chain fatty acids (SCFA) are a source of energy (fuel) for an individual’s cells. They interact with the immune system and are involved in communication between the intestine and the brain. Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. ) (SCFAs) such as butyrate. 

While the scope of this study is limited by its small size and short duration, it confirms that the priority for microbiota health should be the consumption of whole fruits and vegetables in order to fully benefit from their fiber.

Decoding gut health trends on social media

Learn more
Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

A new lens on chlamydia: beyond behavior, into the microbiome

What if the key to predicting and preventing Chlamydia isn’t behavior, but bacteria? A groundbreaking study 1 reveals a vaginal microbiome signature that doubles infection risk and predicts reinfection, reshaping how we understand sexually transmitted infection (STI) vulnerability.

For decades, the conversation around Chlamydia trachomatis, the most common bacterial sexually transmitted infection globally, has revolved around sexual behavior: number of partners, condom use, prior STI history.

But a groundbreaking new study published in Cell  1 invites us to reframe that narrative. Instead of focusing solely on behavior, we’re asked to consider a more intimate and microscopic protagonist: the cervicovaginal microbiome (CVM).

128.5 million In 2020, an estimated 128.5 million new cases of Chlamydia were recorded globally among adults aged 15 to 49. ²

In a longitudinal study, researchers tracked 560 Black and Hispanic adolescent and young adult (AYA) women in New York City, communities disproportionately impacted by Chlamydia infections.

They followed participants before, during, and after an incident Chlamydia infection. But rather than just charting symptoms or behaviors, they analyzed the entire microbial community of the cervicovaginal tract using high-resolution 16S rRNA and ITS1 gene sequencing.

The result? A nuanced and highly predictive microbial fingerprint for Chlamydia risk, reinfection, and even possible complications like pelvic inflammatory disease (PID) and miscarriage.

mBV-A and CST-IV-A: microbial fingerprints of risk

The team used a powerful molecular algorithm (molBV) to quantify bacterial vaginosis (BV)-like states, then categorized microbial communities into “Community State Types” (CSTs).

Among these, CST-IV-A, dominated by Candidatus Lachnocurva vaginae, emerged as the microbial signature most strongly associated with incident Chlamydia infection.

When CST-IV-A overlapped with a high molBV score, a state dubbed mBV-A, the risk of acquiring Chlamydia skyrocketed. Women with this mBV-A profile had more than double the risk of infection compared to those with a Lactobacillus-dominant microbiome (e.g., L. crispatus).

Even more striking? This elevated risk existed months before infection, revealing mBV-A not as a result of Chlamydia, but as a harbinger. This microbial landscape, characterized by high diversity and a drop in protective Lactobacilli, undermines the vaginal environment's natural defenses. It’s not just about pH or lactic acid. 
 

Community State Type (CST)

A classification system used to categorize the vaginal microbiome based on dominant bacterial species. For example, CST-I is typically dominated by Lactobacillus crispatus, while CST-IV includes diverse, non-Lactobacillus species often linked to bacterial vaginosis.

molBV Score (Molecular Bacterial Vaginosis Score)

A computational tool that converts 16S rRNA sequencing data into a Nugent-like score (1–10) to assess bacterial vaginosis status. Higher scores indicate greater dysbiosis, mimicking the diagnostic utility of microscopic BV assessment.

(sidenote: Candidatus Lachnocurva vaginae A bacterium commonly found in women with bacterial vaginosis and strongly associated with CST-IV-A. It is not yet cultivable in the lab ("Candidatus" denotes this) but has been implicated in increased susceptibility to sexually transmitted infections like Chlamydia. ) , the star of CST-IV-A, may metabolize D-lactate, a compound with antimicrobial properties, potentially weakening the cervicovaginal defense against pathogens like Chlamydia.
And it doesn’t stop there. The researchers identified a network of 10 bacterial genera, including Prevotella, Megasphaera, and Clostridium, tightly linked and predictive of infection. These weren’t isolated villains; they were a microbial clique.

Their collective presence formed a (sidenote: Microbial Risk Score (MRS) A composite score representing the cumulative risk posed by a group of specific microbial taxa associated with disease. In this study, it predicts Chlamydia risk based on the presence and abundance of 10 interrelated bacterial genera. ) (MRS), essentially a microbial polygraph test, that outperformed any single genus in predicting Chlamydia acquisition.

Reinfection, recovery, and the microbial set point

Even after treatment, the microbiome tells a story. Most women treated for Chlamydia saw their microbiome shift back toward its pre-infection state. But among those who carried the mBV-A profile post-treatment, the risk of reinfection tripled.

One in five previously infected women experienced reinfection, compared to just 4% of controls. The CVM, in a sense, carried a microbial “memory” of susceptibility, one that wasn't erased by antibiotics.

This points to a deeper truth: treatment of the pathogen does not equal treatment of the terrain. Even more provocatively, the researchers found that some women developed the high-risk mBV-A profile after antibiotic treatment, raising questions about how treatment regimens may unintentionally reshape the microbiome in ways that increase future vulnerability.

There were also early signs, though limited by small sample size, that this microbial fingerprint may be associated with complications like PID and miscarriage. 

What this means for clinical practice

Traditionally, we’ve focused on patient behaviors: partner count, condom use, STI history. These remain important. But now, clinicians may need to consider a biological susceptibility, encoded not in DNA, but in a dynamic microbial ecosystem.

This research doesn’t just challenge the dogma; it builds a roadmap for integrating microbial diagnostics into sexual health. The cervicovaginal microbiome isn’t just a passive passenger. It’s driving women’s care. And it’s time we pay attention to the route it’s taking.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Gynecology

Sensitivity to the additive E466: the role of the microbiota

When it comes to additives, some people are more sensitive than others. And this sensitivity, which varies from one individual to another, seems to be largely based on our gut microbiota. Does this mean that we can predict who is sensitive or not, based on a simple stool analysis?

While (sidenote: Food additives Food additives are substances primarily added to processed foods, or other foods produced on an industrial scale, for technical purposes, e.g. to improve safety, increase the amount of time a food can be stored, or modify sensory properties of food.  Source: World Health Organization )  improve the texture and shelf life of many foods, they also raise health concerns. Some are suspected of promoting chronic inflammatory diseases by acting directly on our gut microbiota.

Nevertheless, the effects vary widely from one individual to another, according to a previous randomized controlled trial in humans (FRESH study: acronym for Functional Research on Emulsifiers in Humans). The additive used: (sidenote: Sodium carboxymethyl cellulose Sodium carboxymethyl cellulose (or cellulose gum, E466) is a food additive with multiple functional properties: firming agent, coating agent, bulking agent, emulsifier, thickener, gelling agent, humectant, stabilizer, etc. Its use is authorized in a wide range of products from dairy products (creams, fresh or processed cheese, dairy desserts, etc.) to cooked fish, from ice creams to dried or canned vegetables, from confectionery to breakfast cereals, from certain meats or fish to mustards and soups, from appetizers to beer or certain spirits, and so on. Source: Food and Agriculture Organization of the United Nations   ) (or E466).

How can this sensitivity be explained or even predicted? The team 1 has continued its previous work by focusing on the microbiota. Their in vitro demonstration used a mini laboratory reactor capable of mimicking the human gut microbiota.

2500 The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has evaluated over 2,500 food additives, approximately 40 contaminants and naturally occurring toxicants, and residues of approximately 90 veterinary drugs. ²

The reactor predicts sensitivity or resistance

When the researchers exposed the microbiota collected from the FRESH study volunteers to carboxymethylcellulose in the bioreactor, they found the same difference in sensitivity as observed in vivo in the FRESH trial: the microbiota of the same 2 of the 7 volunteers exposed to E466 were disturbed when exposed to the emulsifier.

In other words, the microreactor faithfully reproduces the variations between individuals observed in the FRESH trial, making it possible to predict whether a given microbiota is sensitive to E466, without the need for in vivo studies..

Transplanted flora transmit sensitivity to mice

To confirm that this intestinal flora was responsible for the intestinal inflammation observed in some FRESH trial subjects exposed to E466, the microbiota of 2 E466-"sensitive" individuals and 2 non-sensitive individuals were transplanted into flora-free mice.

Only mice given the "sensitive" flora and exposed to the additive developed intestinal inflammation and severe colitis:

  • shortening of the colon
  • damage to the mucosa
  • macrophage infiltration 

Certain bacteria, including Adlercreutzia equolifaciens and Frisingicoccus caecimuris, were associated with this inflammation.

A signature?

It remained to be seen whether a (sidenote: Metagenomics A method of studying the genetic material in samples taken directly from complex natural environments (intestines, oceans, soil, air, etc.), as opposed to samples grown in a laboratory. It produces a description of the genes contained in the sample, as well as an insight into the functional potential of the microbial community.
Source: Riesenfeld CS, Schloss PD, Handelsman J. Metagenomics: genomic analysis of microbial communities. Annu Rev Genet. 2004;38:525-52.
)
signature in stools could have predicted the outcome. Training an algorithm (with the stools of the 7 FRESH volunteers who had consumed E466) identified 78 functional markers of sensitivity.

This signature does make it possible to predict which individuals among the controls in the same study (those not exposed to E466) are sensitive to the additive. However, its application in other cohorts has not been conclusive.

Pending a possible signature, this study highlights new links between the gut microbiota and healthy eating. It also points to the need to consume fewer ultra-processed products (which, like some sweeteners, appear to be detrimental to the health of the gut microbiota).

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Gastroenterology General Medicine